MDT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Medtronic PLC's research and development for the three months ended in Oct. 2014 was $374 Mil. Its research and development for the trailing twelve months (TTM) ended in Oct. 2014 was $1,484 Mil.
This is the expense the company spent on research and development.
Medtronic PLC Research & Development for the trailing twelve months (TTM) ended in Oct. 2014 was 360 (Jan. 2014 ) + 385 (Apr. 2014 ) + 365 (Jul. 2014 ) + 374 (Oct. 2014 ) = $1,484 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Medtronic PLC Annual Data
|Research & Development||951||1,113||1,239||1,275||1,355||1,460||1,472||1,490||1,557||1,477|
Medtronic PLC Quarterly Data
|Research & Development||385||387||376||409||360||372||360||385||365||374|